[Form 4] Aureus Greenway Holdings Inc. Insider Trading Activity

Rhea-AI Filing Summary

Atlas Venture funds have filed Amendment No. 1 to their Schedule 13D for ImageneBio, Inc. (formerly Ikena Oncology, Nasdaq: IKNA) to report dilution of their holdings after the 1-for-12 reverse stock split and completion of Ikena’s all-stock merger with Inmagene on 25 Jul 2025.

• Collectively, the reporting entities now own 418,179 post-split common shares, equal to 3.6 % of the 11.6 million shares outstanding.
• Breakdown: Fund X 241,800 shares (2.1 %), Fund XI 103,494 shares (0.9 %), Opportunity Fund I 72,885 shares (0.6 %).
• All voting and dispositive powers are shared among the respective limited partnerships and their general partners; no sole voting power is reported.
• The funds ceased to be 5 % beneficial owners on 25 Jul 2025; no purchases or sales occurred in the past 60 days.
• Purpose: administrative update reflecting dilution from the merger and reverse split; Atlas Venture continues to hold the same absolute number of economic shares pre-transaction but a lower percentage.

Atlas Venture disclaims group status among the reporting persons. A joint filing agreement is included as Exhibit 99.1.

Insights

Financial Analyst

TL;DR – Atlas Venture’s stake falls to 3.6 % due to merger-related dilution; no shares sold, impact on IKNA share supply already known.

The amendment is largely administrative. Atlas Venture’s absolute share count is unchanged, but the completed Inmagene merger and 1-for-12 reverse split expanded the denominator, cutting their ownership below the 5 % 13D threshold. The filing removes a potential overhang concern of insider selling, as none occurred. From a governance lens, the reduced concentration slightly broadens the float, but Atlas remains a meaningful holder. Market impact is likely minimal because the share count change was disclosed in the July 25 reverse-split announcement and already reflected in trading. Overall, neutral for valuation and liquidity.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Cheung Ching Ping Stephen

(Last) (First) (Middle)

19-23 TUNG LO WAN ROAD,

CAUSEWAY BAY

(Street)

HONG KONG 999077

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Aureus Greenway Holdings Inc [ AGH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
07/25/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/25/2025	07/25/2025	S		2,000,000	D	$0.975	3,290,000	I	By Ace Champion Investments Limited(1)
Series A Preferred Stock	07/25/2025	07/25/2025	S		5,000,000	D	$0.01	0	I	By Ace Champion Investments Limited(1)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. As of July 28, 2025, Ace Champion Investments Limited, a company owned and controlled by Stephen Ching Ping Cheung, owned 3,290,000 shares of common stock and 0 shares of series A preferred stock of the Issuer.

	/s/ Stephen Ching Ping Cheung	07/29/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.